Longboard Pharmaceuticals (LBPH)
(Delayed Data from NSDQ)
$20.69 USD
+0.18 (0.88%)
Updated May 17, 2024 04:00 PM ET
After-Market: $20.70 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Brokerage Reports
Longboard Pharmaceuticals, Inc. [LBPH]
Reports for Purchase
Showing records 21 - 40 ( 57 total )
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Waiting on PACIFIC, An Uneventful 3Q23 Update For Now
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
LP352 Time To Shine Approaches With PACIFIC Readout Tracking to January
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Investor Event Highlights Potential Blockbuster LP352 Differentiation in Epilepsy; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Key Takeaways From 25th Annual Global Conference: Multiple Underappreciated Programs to Shine in 2H23 and 2024
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
PACIFIC Enrollment Completes, Keeping 4Q23 Readout On Track
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
2Q23 Results; LP352 PACIFIC Readout on Track for 4Q23; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
All Cylinders Continuing to Fire Ahead of Upcoming PACIFIC Data Readout
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Takeaways From Recent Conferences: Nearing a Psychedelic Breakout With Plethora of Catalysts; LP352 to Shine in Epilepsy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
PACIFIC Data in Lead Epilepsy Program on Track for 4Q23
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
1Q23 Results; Phase 1b/2a Data on Lead Epilepsy Compound LP352 on Track for 4Q23
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Notes From The (Virtual) Road... Check-In With Management Ahead of PACIFIC Data
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
California Dreamin'' As PACIFIC Data On Track For 4Q23
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Longboard Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
4Q22 Results; Lead Epilepsy Compound LP352 on Track for Phase 2 Data in 2H23; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P